Sio Capital Management, LLC Logic Bio Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.35 - $0.74 $63,920 - $135,146	-182,630 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.03 - $7.57 $735,998 - $1.38 Million	182,630 New	182,630 $811,000
Q1 2020 May 15, 2020	SELL	$4.06 - $11.0 $510,894 - $1.38 Million	-125,836 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.01 - $11.01 $23,133 - $36,333	3,300 Added 2.69%	125,836 $906,000
Q3 2019 Nov 14, 2019	SELL	$6.97 - $13.46 $69,727 - $134,653	-10,004 Reduced 7.55%	122,536 $1.33 Million
Q2 2019 Aug 14, 2019	SELL	$9.77 - $17.08 $258,103 - $451,219	-26,418 Reduced 16.62%	132,540 $1.72 Million
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $1.25 Million - $2.86 Million	158,958 New	158,958 $1.65 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.